Table 2. Final treatment outcomes assigned before January 1, 2017 for patients enrolled in the SOC (January 2010—July 2013) and SAT (January 2012—December 2014) cohorts who completed at least 6 months of treatment.

Final RR-TB treatment outcomes	SOC-cohort n = 118 n (%)	SAT-cohort n = 174 n (%)	P-value
Treatment success	66 (55.9%)	99 (56.9%)	0.87
Loss from Treatment	25 (21.2%)	31 (17.8%)	0.47
Death	6 (5.1%)	15 (8.6%)	0.25
Treatment Failure	5 (4.2%)	7 (4.0%)	0.93
Not Evaluated	16 (13.6%)	22 (12.6%)	0.82

RR-TB, rifampicin-resistant tuberculosis; SOC, standard of care; SAT, self-administered treatment.